Expression and function of TRK-B and BDNF in human neuroblastomas
about
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaTropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancerRegulatory networks between neurotrophins and miRNAs in brain diseases and cancersThe p75 neurotrophin receptor is a central regulator of glioma invasionFine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survivalIncreased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomasA cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiationCyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in miceHOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptomeAssociation between favorable neuroblastoma and high expression of the novel metalloproteinase gene, nbla3145/XCE, cloned by differential screening of the full-length-enriched oligo-capping neuroblastoma cDNA libraries.Hunting the subset-specific genes of neuroblastoma: expression profiling and differential screening of the full-length-enriched oligo-capping cDNA libraries.Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.Identification of dynamic proteome changes upon ligand activation of Trk-receptors using two-dimensional fluorescence difference gel electrophoresis and mass spectrometry.The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.Diagnosis and classification of the small round-cell tumors of childhood.Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.An enhancer element for expression of the Ncx (Enx, Hox11L1) gene in neural crest-derived cells.In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosinePreclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.Ciliary neurotrophic factor reduces the proliferation and promotes the differentiation of TH- MYCN transformed sympathoadrenal progenitors.Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling.Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganizationTrk receptor expression and inhibition in neuroblastomasPhase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.Therapeutic targets for neuroblastomas.Rotary bioreactor culture can discern specific behavior phenotypes in Trk-null and Trk-expressing neuroblastoma cell lines.Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptorRole and relevance of TrkB mutations and expression in non-small cell lung cancer.Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.Genomic medicine and neuroblastoma.Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.Biological role of anaplastic lymphoma kinase in neuroblastoma.Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression.Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo.Clinical significance of NTRK family gene expression in neuroblastomasExpression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis.Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cellsAssociation of neurotrophin receptor expression and differentiation in human neuroblastoma.
P2860
Q24594695-43775802-3A85-43EB-894C-86512A78F864Q26774713-81874253-279D-48C3-828B-DA996F53279BQ26864655-7BD43277-2713-4046-88C4-B2EC5CAC388EQ27334481-0AA898C3-E327-440D-9EE8-C4AD75E253A7Q28249554-DAAD945E-BA98-4212-B71B-5EE3BA13BBEBQ28281864-D0D5415D-712D-4447-9767-695C8FAD6034Q28472217-663E2322-81D7-4DE1-A6FA-EEA25F98D9C2Q28473290-2539312B-D24F-4A05-A1E5-2A779D70225BQ28652372-536EF2CD-A5F6-4187-9D98-B91B22FF117BQ30660024-AEA42A9B-4A05-4C9C-8053-B5195BFD27ADQ30975716-E48D3AD7-C9A3-4644-BF3E-530269BB5ADEQ32063203-6B162AA2-9762-4ABA-BF33-DB9133ABC9FCQ33210960-7C2E23F4-C14B-44A5-A2D0-EE0C53EE94C0Q33643120-5751EF38-8DD8-4E76-8264-0378D6255C2EQ33679402-65CBF1FA-D055-4F5E-8DD8-3D8D7CE0EB23Q33829455-8488172A-5A26-4EF6-B52A-C1BC13356780Q33870880-E11CD5D2-6A3C-4901-A38C-C821F9556955Q33888833-844A70FD-97FC-4E76-8D00-1169F6009575Q34055511-5C459DEF-40A9-431F-9236-E26AE3CEB8E4Q34243956-A4D759DA-FA40-4041-A9CB-D4F4B19E0C0DQ34351731-A4F094AA-D3EB-40AB-A18A-730FE362E629Q34387629-21BD5E86-94BF-4DA2-8F59-07BDAA1884ABQ34533814-CE4B0E05-09A0-44BD-BF3F-463187D509C0Q34549157-CD207E5D-13F1-4603-A531-CFEEB3F28473Q34549193-5EBC274E-44FC-4528-BB9C-702F20B8A81AQ34560877-A2155791-871C-467B-BC65-ED92570D2034Q34569243-E8523991-B5AC-40E9-95EC-37B59F593868Q34588700-4CD1F632-3421-416C-9019-DCECAC29F3E6Q34917434-C9888B11-6CEC-40A2-B94E-06CA76B08D70Q34956841-9FFA66A7-74FD-4A83-A0B3-A57F0744B7B7Q35045279-074E8AD5-4A04-4BD7-9621-F2CE87739A5AQ35067781-2A9BAB34-D0CA-490E-B3AB-713E26B22386Q35084934-0C71AC2E-AE77-4FE5-A469-77DF61C4A817Q35097218-781C5986-72A7-4743-AB85-316A291B6AE5Q35131575-12B467E4-DD77-4F26-A08B-2C5F14D0A929Q35173154-C588AD83-0104-4F10-9F31-EAFD19FD55FEQ35673178-F983D29F-9623-45AB-BB38-62CDCF23E50BQ35723535-E2351ED5-578A-41AB-8C08-C72FA1DDF56AQ35788080-C7AF562E-4A9D-492C-8960-6F1F7F9A6462Q35796376-92127546-3343-4126-BDC0-E95528EAD907
P2860
Expression and function of TRK-B and BDNF in human neuroblastomas
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Expression and function of TRK-B and BDNF in human neuroblastomas
@ast
Expression and function of TRK-B and BDNF in human neuroblastomas
@en
type
label
Expression and function of TRK-B and BDNF in human neuroblastomas
@ast
Expression and function of TRK-B and BDNF in human neuroblastomas
@en
prefLabel
Expression and function of TRK-B and BDNF in human neuroblastomas
@ast
Expression and function of TRK-B and BDNF in human neuroblastomas
@en
P2093
P2860
P356
P1476
Expression and function of TRK-B and BDNF in human neuroblastomas
@en
P2093
A Nakagawara
G M Brodeur
N J Scavarda
P2860
P304
P356
10.1128/MCB.14.1.759
P407
P577
1994-01-01T00:00:00Z